Home › Agent Hub › Agent Tools › Part D coverage by drug › Farxiga
Agent Tools
Farxiga is a brand of dapagliflozin. What agents check before quoting it: how many 2026 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2026, 3,162 of 5,496 Medicare Part D and Medicare Advantage drug plans (57.5%) list Farxiga on their formulary, across 112 of 328 formularies. The most common placement is tier 3 (3,047 plans, 96.4% of those covering it). 0 of the covering plans require prior authorization (0%), 0 step therapy and 3,136 a quantity limit. Generic dapagliflozin is on 5,496 of 5,496 plans (100%).
1,199 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $47, 56 of them $0; 1,963 charge coinsurance instead — median 24% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,100 in 2026, covered drugs cost $0 for the rest of the year.
Farxiga has a Medicare negotiated price (maximum fair price) of $178.50 for a 30-day supply, which applies. The negotiated price lowers what the plan pays; the member's copay or coinsurance still follows the plan's tier.
2025: 5,435 of 5,631 plans covered it (96.5%); 2026: 3,162 of 5,496 (57.5%).
Of 4,368 plans offered in both years, 70 added it to the formulary and 1,888 dropped it.
Among plans covering it both years, 183 moved it to a higher tier and 712 to a lower one; 0 added prior authorization and 0 removed it.
Medicare Part D paid for 9,824,198 30-day fills of Farxiga in 2024 for about 1,268,791 enrollees, at an average total cost of $537.32 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Farxiga and the rest of a client's list on every plan in their county.
Estimate Farxiga costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 09/16/2026). CMS formulary data.